CalciMedica, Common Company Insiders
CALC Stock | 3.09 0.08 2.52% |
CalciMedica, Common's insiders are aggressively buying. The analysis of the overall insider sentiment regarding CalciMedica, Common Stock suggests that all insiders are extremely bullish. CalciMedica, Common employs about 13 people. The company is managed by 13 executives with a total tenure of roughly 31 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive.
CalciMedica, Common's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
2024-12-06 | Fred A Middleton | Acquired 4800 @ 2.65 | View | ||
2024-11-01 | Sanderling Venture Partners Vi | Acquired 86867 @ 3.75 | View | ||
2024-08-27 | A. Rachel Leheny | Acquired 1000 @ 4.19 | View | ||
2024-08-23 | Robert N Wilson | Acquired 54000 @ 3.72 | View | ||
2024-08-21 | Eric W Roberts | Acquired 5000 @ 4.04 | View | ||
2024-06-27 | Robert N Wilson | Acquired 8443 @ 3.23 | View | ||
2024-04-01 | Eric W Roberts | Acquired 746 @ 3.9 | View | ||
2024-01-23 | Sanderling Venture Partners Vi | Acquired 243356 @ 3.7 | View |
Monitoring CalciMedica, Common's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
CalciMedica, |
CalciMedica, Common Management Team Effectiveness
The company has return on total asset (ROA) of (0.6492) % which means that it has lost $0.6492 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8376) %, meaning that it created substantial loss on money invested by shareholders. CalciMedica, Common's management efficiency ratios could be used to measure how well CalciMedica, Common manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -3.08. The current year's Return On Capital Employed is expected to grow to -2.93. As of January 20, 2025, Total Assets is expected to decline to about 10.4 M. In addition to that, Non Current Assets Total is expected to decline to about 495.9 KThe current year's Common Stock Shares Outstanding is expected to grow to about 5.4 M, whereas Net Loss is forecasted to decline to (13.7 M).
CalciMedica, Common Workforce Comparison
CalciMedica, Common Stock is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 104,879. CalciMedica, Common adds roughly 13.0 in number of employees claiming only tiny portion of equities under Health Care industry.
CalciMedica, Common Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CalciMedica, Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on CalciMedica, Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CalciMedica, Common insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-09-01 | 16.0 | 16 | 1 | 526,761 | 11,761 |
2009-12-01 | 43.0 | 43 | 1 | 800,153 | 0.00 |
2006-09-01 | 2.0 | 2 | 1 | 529,992 | 264,996 |
2006-03-01 | 1.0 | 1 | 1 | 10,000 | 10,000 |
2005-03-01 | 2.5455 | 28 | 11 | 120,118 | 52,800 |
CalciMedica, Common Notable Stakeholders
A CalciMedica, Common stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CalciMedica, Common often face trade-offs trying to please all of them. CalciMedica, Common's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CalciMedica, Common's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kenneth Stauderman | CoFounder Officer | Profile | |
Stefan MD | CoFounder Advisor | Profile | |
Patrick Hogan | CoFounder Advisor | Profile | |
Anjana Rao | CoFounder Advisor | Profile | |
Rachel Leheny | CEO Director | Profile | |
Michael MBA | President COO | Profile | |
MBA MBA | President COO | Profile | |
Eric Roberts | Chief Board | Profile | |
John JD | General Counsel | Profile | |
Raven MS | Chief Officer | Profile | |
Cindy Reiedenberg | Accountant | Profile | |
Daniel MBA | Interim Officer | Profile | |
Sudarshan MD | Chief Officer | Profile |
About CalciMedica, Common Management Performance
The success or failure of an entity such as CalciMedica, Common Stock often depends on how effective the management is. CalciMedica, Common management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CalciMedica, management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CalciMedica, management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (3.24) | (3.08) | |
Return On Capital Employed | (3.08) | (2.93) | |
Return On Assets | (3.24) | (3.08) | |
Return On Equity | (4.84) | (4.60) |
Please note, the presentation of CalciMedica, Common's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CalciMedica, Common's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CalciMedica, Common's management manipulating its earnings.
CalciMedica, Common Workforce Analysis
Traditionally, organizations such as CalciMedica, Common use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CalciMedica, Common within its industry.CalciMedica, Common Manpower Efficiency
Return on CalciMedica, Common Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 2.6M | |
Net Loss Per Executive | 2.6M | |
Working Capital Per Employee | 582.8K | |
Working Capital Per Executive | 582.8K |
Complementary Tools for CalciMedica, Stock analysis
When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |